Antimicrobial Susceptibility Patterns of Escherichia coli among Tunisian Outpatients with Community-Acquired Urinary Tract Infection (2012-2018)
Authors:
Open Access
- 1 December 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Current Urology
- Vol. 14 (4) , 200-205
Abstract
Introduction: Community-acquired urinary tract infection is one of the most common reasons for consultation in everyday practice; it represents a major source of antibiotic consumption. Escherichia coli (E. coli) is the main pathogen incriminated. Objective:· The aim of this study was to evaluate antimicrobial susceptibility patterns of community-acquired uropathogenic E coli throughout a 7-year period. Methodology: All strains of E. coli isolated from urine samples between January 1st 2012 and December 31st 2018 were included. Presence of ≥ 103 CFU/ml in urine culture media was considered as significant for urinary tract infection. The identification of E. coli strains was realized using standard laboratory techniques. Antibiotic susceptibility testing was performed using the disk diffusion method according to the CA-SFM/ EUCAST criteria. Results: A total of 1,335 E. coli strains were isolated. Overall susceptibility rates to antimicrobial agents were as follows: ampicillin 39.1%, amoxicillin-clavulanic acid 64.9%, cefotaxime 94.9%, trimethoprim/sulfamethox-azole 67.6%, ciprofloxacin 89.2%, ofloxacin 86.9%, amikacin 98.6%, gentamicin 93.9%, nitrofurantoin 97.6% and fosfomycin 99.3%. All isolates were susceptible to carbapenems. The frequency of extended spectrum beta-lactamases-producing E. coli strains was 4.7%. Susceptibility rates of E. coli for ampicillin, trimethoprim/sulfamethoxazole and amikacin remained relatively stable over the study period, whereas susceptibility to amoxicillin-clavulanic acid, cefotaxime and fluoroquinolones showed a 2-phase pattern. As for gentamicin, a continuous decrease in susceptibility rates was observed. Conclusion: Antimicrobial susceptibility profiles of uropathogenic E. coli are constantly changing, due to modifications in the antibiogram interpretation criteria and antibiotic prescription habits. Rigorous surveillance of resistance rate is necessary to determine appropriate empirical treatment and limit the spread of multiresistant strains.Keywords
This publication has 22 references indexed in Scilit:
- Profil actuel de résistance aux antibiotiques des souches d’Escherichia coli uropathogènes et conséquences thérapeutiquesProgrès en Urologie, 2014
- Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, ChinaThe Journal of Antibiotics, 2014
- The Antibiotic Susceptibility Patterns of Uropathogenic Escherichia Coli , With Special Reference to the FluoroquinolonesJournal of Clinical and Diagnostic Research, 2013
- In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010Antimicrobial Agents and Chemotherapy, 2012
- Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisitedInternational Journal of Antimicrobial Agents, 2012
- Antibiotic susceptibility patterns of urinary pathogens in female outpatientsNorth American Journal of Medical Sciences, 2012
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year intervalJournal of Antimicrobial Chemotherapy, 2010
- Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trialsJournal of Antimicrobial Chemotherapy, 2010
- The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infectionsInternational Journal of Antimicrobial Agents, 2009